These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29029677)

  • 41. Self-reported sleep quality of patients with atrial fibrillation and the effects of cardioversion on sleep quality.
    Kayrak M; Gul EE; Aribas A; Akilli H; Alibasiç H; Abdulhalikov T; Yildirim O; Yazici M; Ozdemir K
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):823-9. PubMed ID: 23437796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study.
    Roalfe AK; Bryant TL; Davies MH; Hackett TG; Saba S; Fletcher K; Lip GY; Hobbs FD; Mant J;
    Europace; 2012 Oct; 14(10):1420-7. PubMed ID: 22581625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accuracy of patient perception of their prevailing rhythm: a comparative analysis of monitor data and questionnaire responses in patients with atrial fibrillation.
    Garimella RS; Chung EH; Mounsey JP; Schwartz JD; Pursell I; Gehi AK
    Heart Rhythm; 2015 Apr; 12(4):658-65. PubMed ID: 25595926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of atrial fibrillation monitor characteristics to predict severity of symptoms of atrial fibrillation.
    Patel N; Chung EH; Mounsey JP; Schwartz JD; Pursell I; Gehi AK
    Am J Cardiol; 2014 May; 113(10):1674-8. PubMed ID: 24698459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biatrial linear ablation in sustained nonpermanent AF: Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial.
    Wynn GJ; Panikker S; Morgan M; Hall M; Waktare J; Markides V; Hussain W; Salukhe T; Modi S; Jarman J; Jones DG; Snowdon R; Todd D; Wong T; Gupta D
    Heart Rhythm; 2016 Feb; 13(2):399-406. PubMed ID: 26455343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation.
    Spertus J; Dorian P; Bubien R; Lewis S; Godejohn D; Reynolds MR; Lakkireddy DR; Wimmer AP; Bhandari A; Burk C
    Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):15-25. PubMed ID: 21160035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of short-term exercise training on symptoms and quality of life in patients with chronic atrial fibrillation.
    Hegbom F; Stavem K; Sire S; Heldal M; Orning OM; Gjesdal K
    Int J Cardiol; 2007 Mar; 116(1):86-92. PubMed ID: 16815571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A high quality of life is maintained late after Maze III surgery for atrial fibrillation.
    Lönnerholm S; Blomström P; Nilsson L; Blomström-Lundqvist C
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):558-62. PubMed ID: 19520588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hybrid therapy with right atrial catheter ablation and previously ineffective antiarrhythmic drugs for the management of atrial fibrillation.
    Kocheril AG; Calkins H; Sharma AD; Cher D; Stubbs HA; Block JE
    J Interv Card Electrophysiol; 2005 Apr; 12(3):189-97. PubMed ID: 15875109
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paroxysmal atrial fibrillation, quality of life and neuroticism.
    van den Berg MP; Ranchor AV; van Sonderen FL; van Gelder IC; van Veldhuisen DJ
    Neth J Med; 2005 May; 63(5):170-4. PubMed ID: 15952485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs.
    Reynolds MR; Walczak J; White SA; Cohen DJ; Wilber DJ
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):615-23. PubMed ID: 20940250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New classification scheme for atrial fibrillation symptom severity and burden.
    Koci F; Forbes P; Mansour MC; Heist EK; Singh JP; Ellinor PT; Ruskin JN
    Am J Cardiol; 2014 Jul; 114(2):260-5. PubMed ID: 24878121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pulmonary vein isolation combined with spironolactone or renal sympathetic denervation in patients with chronic kidney disease, uncontrolled hypertension, paroxysmal atrial fibrillation, and a pacemaker.
    Kiuchi MG; Chen S; Hoye NA; Pürerfellner H
    J Interv Card Electrophysiol; 2018 Jan; 51(1):51-59. PubMed ID: 29264729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atrial fibrillation onset circumstances and their relation to patients' quality of life.
    Maryniak A; Walczak F; Bodalski R; Szumowski L; Derejko P; Urbanek P; Orczykowski M; Szufladowicz E
    Kardiol Pol; 2006 Oct; 64(10):1102-8; discussion 1109. PubMed ID: 17089242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation.
    Simpson CS; Yee R; Lee JK; Braney M; Klein GJ; Krahn AD; Skanes AC
    Am Heart J; 2001 Aug; 142(2):294-300. PubMed ID: 11479469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation.
    Gillis AM; Koehler J; Morck M; Mehra R; Hettrick DA
    Heart Rhythm; 2005 Aug; 2(8):791-6. PubMed ID: 16051111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychological correlates of quality of life in atrial fibrillation.
    Ong L; Cribbie R; Harris L; Dorian P; Newman D; Mangat I; Nolan R; Irvine J
    Qual Life Res; 2006 Oct; 15(8):1323-33. PubMed ID: 16826433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.
    Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GY
    Europace; 2016 May; 18(5):648-57. PubMed ID: 26826133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial Fibrillation.
    Dorian P; Mangat I
    Card Electrophysiol Rev; 2003 Sep; 7(3):276-9. PubMed ID: 14739727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Internet-delivered CBT for children with specific phobia: a pilot study.
    Vigerland S; Thulin U; Ljótsson B; Svirsky L; Ost LG; Lindefors N; Andersson G; Serlachius E
    Cogn Behav Ther; 2013; 42(4):303-14. PubMed ID: 24245708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.